跳转至内容
Merck
CN

SML2765

Glutor

≥98% (HPLC), glucose uptake inhibitor, powder

别名:

(S)-6-Methyl-5-(4-morpholinobenzyl)-4-oxo-2-phenyl-N-(pyridin-3-ylmethyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine-6-carboxamide

登录 查看组织和合同定价。

选择尺寸


关于此项目

经验公式(希尔记法):
C31H32N6O3
分子量:
536.62
UNSPSC Code:
12352200
NACRES:
NA.77
Assay:
≥98% (HPLC)
Form:
powder
Quality level:
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

Glutor, ≥98% (HPLC)

assay

≥98% (HPLC)

form

powder

color

white to beige

solubility

DMSO: 2 mg/mL, clear

storage temp.

2-8°C

Quality Level

Biochem/physiol Actions

Glutor is a potent inhibitor of glucose uptake that targets glucose transporters GLUT1, -2, and -3. Inhibition of glucose uptake by glutor leads to upregulation of GLUT3 and GLUT1 expression. Glutor potently and selectively suppresses growth of a variety of cancer cell lines. Glutor and glutaminase inhibitor CB-839 synergistically inhibit tumor cell growth.
potent inhibitor of glucose uptake that targets glucose transporters GLUT-1, -2, and -3

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Elena S Reckzeh et al.
Cell chemical biology, 26(9), 1214-1228 (2019-07-16)
Cancer cells sustain growth by altering their metabolism to accelerated aerobic glycolysis accompanied by increased glucose demand and employ glutamine as additional nutrient source. This metabolic adaptation induces upregulation of glucose transporters GLUT-1 and -3, and simultaneous targeting of both

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持